Promising plasmid DNA vector based on APTES-modified silica nanoparticles

Tuck-yun Cheang1,*, Bing Tang1,*, An-wu Xu2, Guang-qi Chang1, Zuo-jun Hu1, Wei-ling He1, Zhou-hao Xing2, Jian-bo Xu1, Mian Wang1, Shen-ming Wang11Department of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; 2Division of Nanomaterials and Chemistry, Hefei...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cheang TY, Tang B, Xu AW, Chang GQ, Hu ZJ, He WL, Xing ZH, Xu JB, Wang M, Wang SM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/bce4bde9a396456492b272c09633261b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bce4bde9a396456492b272c09633261b
record_format dspace
spelling oai:doaj.org-article:bce4bde9a396456492b272c09633261b2021-12-02T05:02:08ZPromising plasmid DNA vector based on APTES-modified silica nanoparticles1176-91141178-2013https://doaj.org/article/bce4bde9a396456492b272c09633261b2012-02-01T00:00:00Zhttp://www.dovepress.com/promising-plasmid-dna-vector-based-on-aptes-modified-silica-nanopartic-a9330https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Tuck-yun Cheang1,*, Bing Tang1,*, An-wu Xu2, Guang-qi Chang1, Zuo-jun Hu1, Wei-ling He1, Zhou-hao Xing2, Jian-bo Xu1, Mian Wang1, Shen-ming Wang11Department of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; 2Division of Nanomaterials and Chemistry, Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, China  *Both authors contributed equally to this workAbstract: Nanoparticles have an enormous potential for development in biomedical applications, such as gene or drug delivery. We developed and characterized aminopropyltriethoxysilane-functionalized silicon dioxide nanoparticles (APTES-SiNPs) for gene therapy. Lipofectamine® 2000, a commonly used agent, served as a contrast. We showed that APTES-SiNPs had a gene transfection efficiency almost equal to that of Lipofectamine 2000, but with lower cytotoxicity. Thus, these novel APTES-SiNPs can achieve highly efficient transfection of plasmid DNA, and to some extent reduce cytotoxicity, which might overcome the critical drawbacks in vivo of conventional carriers, such as viral vectors, organic polymers, and liposomes, and seem to be a promising nonviral gene therapy vector.Keywords: aminopropyltriethoxysilane, silicon dioxide nanoparticles, Lipofectamine® 2000, gene therapy vector, nanomedicineCheang TYTang BXu AWChang GQHu ZJHe WLXing ZHXu JBWang MWang SMDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 1061-1067 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Cheang TY
Tang B
Xu AW
Chang GQ
Hu ZJ
He WL
Xing ZH
Xu JB
Wang M
Wang SM
Promising plasmid DNA vector based on APTES-modified silica nanoparticles
description Tuck-yun Cheang1,*, Bing Tang1,*, An-wu Xu2, Guang-qi Chang1, Zuo-jun Hu1, Wei-ling He1, Zhou-hao Xing2, Jian-bo Xu1, Mian Wang1, Shen-ming Wang11Department of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; 2Division of Nanomaterials and Chemistry, Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, China  *Both authors contributed equally to this workAbstract: Nanoparticles have an enormous potential for development in biomedical applications, such as gene or drug delivery. We developed and characterized aminopropyltriethoxysilane-functionalized silicon dioxide nanoparticles (APTES-SiNPs) for gene therapy. Lipofectamine® 2000, a commonly used agent, served as a contrast. We showed that APTES-SiNPs had a gene transfection efficiency almost equal to that of Lipofectamine 2000, but with lower cytotoxicity. Thus, these novel APTES-SiNPs can achieve highly efficient transfection of plasmid DNA, and to some extent reduce cytotoxicity, which might overcome the critical drawbacks in vivo of conventional carriers, such as viral vectors, organic polymers, and liposomes, and seem to be a promising nonviral gene therapy vector.Keywords: aminopropyltriethoxysilane, silicon dioxide nanoparticles, Lipofectamine® 2000, gene therapy vector, nanomedicine
format article
author Cheang TY
Tang B
Xu AW
Chang GQ
Hu ZJ
He WL
Xing ZH
Xu JB
Wang M
Wang SM
author_facet Cheang TY
Tang B
Xu AW
Chang GQ
Hu ZJ
He WL
Xing ZH
Xu JB
Wang M
Wang SM
author_sort Cheang TY
title Promising plasmid DNA vector based on APTES-modified silica nanoparticles
title_short Promising plasmid DNA vector based on APTES-modified silica nanoparticles
title_full Promising plasmid DNA vector based on APTES-modified silica nanoparticles
title_fullStr Promising plasmid DNA vector based on APTES-modified silica nanoparticles
title_full_unstemmed Promising plasmid DNA vector based on APTES-modified silica nanoparticles
title_sort promising plasmid dna vector based on aptes-modified silica nanoparticles
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/bce4bde9a396456492b272c09633261b
work_keys_str_mv AT cheangty promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
AT tangb promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
AT xuaw promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
AT changgq promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
AT huzj promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
AT hewl promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
AT xingzh promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
AT xujb promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
AT wangm promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
AT wangsm promisingplasmiddnavectorbasedonaptesmodifiedsilicananoparticles
_version_ 1718400791948034048